ERAS Form 144 Shows Small Monthly Share Sales by Erasca Foundation

Rhea-AI Filing Summary

Erasca, Inc. (ERAS) reported a Form 144 notice showing proposed and recent sales of its common stock by an affiliated seller. The notice lists a proposed sale of 8,333 shares to be executed on 08/15/2025 on Nasdaq with an aggregate market value of $12,834.87. The shares were originally acquired by donation on 07/20/2021 from Erasca, Inc., with the donor amount recorded as 10,193,557 shares at donation. The filing also discloses three recent monthly sales by the Erasca Foundation of 8,333 shares each on 05/15/2025, 06/16/2025 and 07/15/2025, producing gross proceeds of $10,146.29, $12,090.87 and $12,094.60 respectively. The filing includes standard representations about absence of undisclosed material information and trading-plan attestations.

Insights

Securities Analyst

TL;DR: Small recurring sales by an affiliated foundation; volume is immaterial versus outstanding shares.

The Form 144 shows the Erasca Foundation selling 8,333-share tranches monthly and a proposed additional 8,333-share sale. Against the issuer's reported 283,670,139 shares outstanding, each tranche represents roughly 0.003% of outstanding stock, and the aggregate market values shown (~$10k–$13k per tranche) are immaterial to company capitalization. For investors, this filing documents insider-affiliated liquidity activity but does not indicate a material change to supply or ownership stakes.

Corporate Governance Expert

TL;DR: Disclosure appears procedurally complete; transactions stem from a prior donation and are being reported under Rule 144.

The report attributes the shares to a donation dated 07/20/2021 and identifies the seller as Erasca Foundation. The filing includes the required attestation regarding undisclosed material information and references potential Rule 10b5-1 plan adoption. From a governance perspective, this is routine compliance reporting of secondary sales by an affiliated charitable entity rather than an operational or executive governance change.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 6002 El Tordo 2nd FL PO BOX 7297 Rancho Santa Fe CA 92067	8333	12834.87	283670139	08/15/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/20/2021	Donation	Erasca, Inc			10193557	07/20/2021	Donation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Erasca Foundation 3115 MERRYFIELD ROW Ste 300 San Digo CA 92121	Common	07/15/2025	8333	12094.60
Erasca Foundation 3115 MERRYFIELD ROW Ste 300 San Diego CA 92121	Common	06/16/2025	8333	12090.87
Erasca Foundation 3115 MERRYFIELD ROW Ste 300 San Diego CA 92121	Common	05/15/2025	8333	10146.29

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ERAS Form 144 disclose about proposed sales?

The notice lists a proposed sale of 8,333 common shares on 08/15/2025 on Nasdaq with an aggregate market value of $12,834.87.

Who is selling ERAS shares according to the filing?

The seller is listed as the Erasca Foundation, and the shares were originally acquired by donation from Erasca, Inc. on 07/20/2021.

How many shares has the Erasca Foundation sold recently?

The filing shows three recent sales of 8,333 shares each on 05/15/2025, 06/16/2025, and 07/15/2025, with gross proceeds of $10,146.29, $12,090.87, and $12,094.60 respectively.

How large are these sales relative to ERAS outstanding shares?

The filing reports 283,670,139 shares outstanding; each 8,333-share tranche equals roughly 0.003% of outstanding shares, indicating immaterial volume.

Does the filing indicate any undisclosed material information?

By signing the notice, the person for whose account the securities will be sold represents they do not know any material adverse information about the issuer that has not been publicly disclosed.